[go: up one dir, main page]

EE03803B1 - a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid - Google Patents

a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid

Info

Publication number
EE03803B1
EE03803B1 EE9600109A EE9600109A EE03803B1 EE 03803 B1 EE03803 B1 EE 03803B1 EE 9600109 A EE9600109 A EE 9600109A EE 9600109 A EE9600109 A EE 9600109A EE 03803 B1 EE03803 B1 EE 03803B1
Authority
EE
Estonia
Prior art keywords
dipeptides
mixtures
amino
cyclopentane
derivatives
Prior art date
Application number
EE9600109A
Other languages
English (en)
Estonian (et)
Other versions
EE9600109A (et
Inventor
Matzke Michael
Militzer Hans-Christian
Mittendorf Joachim
Kunisch Franz
Schmidt Axel
Sch�nfeld Wolfgang
Ziegelbauer Karl
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of EE9600109A publication Critical patent/EE9600109A/xx
Publication of EE03803B1 publication Critical patent/EE03803B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
EE9600109A 1995-07-19 1996-07-18 a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid EE03803B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19526274A DE19526274A1 (de) 1995-07-19 1995-07-19 Verbesserung der Verträglichkeit von pharmazeutisch wirksamen beta-Aminosäuren

Publications (2)

Publication Number Publication Date
EE9600109A EE9600109A (et) 1997-02-17
EE03803B1 true EE03803B1 (et) 2002-08-15

Family

ID=7767189

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600109A EE03803B1 (et) 1995-07-19 1996-07-18 a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid

Country Status (45)

Country Link
US (1) US5935988A (xx)
EP (2) EP1043332B1 (xx)
JP (2) JP3891503B2 (xx)
KR (1) KR100433968B1 (xx)
CN (1) CN1115145C (xx)
AR (1) AR003465A1 (xx)
AT (2) ATE344274T1 (xx)
AU (1) AU713555B2 (xx)
BG (1) BG62134B1 (xx)
BR (1) BR9603124A (xx)
CA (1) CA2181308A1 (xx)
CO (1) CO4700525A1 (xx)
CU (1) CU22820A3 (xx)
CZ (2) CZ287896B6 (xx)
DE (3) DE19526274A1 (xx)
DK (2) DK1043332T3 (xx)
DZ (1) DZ2073A1 (xx)
EE (1) EE03803B1 (xx)
ES (2) ES2154761T3 (xx)
GR (1) GR3035601T3 (xx)
HK (1) HK1005131A1 (xx)
HR (1) HRP960303B1 (xx)
HU (1) HUP9601977A3 (xx)
IL (1) IL118869A (xx)
MA (1) MA23940A1 (xx)
MX (1) MX9602836A (xx)
NO (1) NO315926B1 (xx)
NZ (1) NZ299008A (xx)
PE (1) PE9398A1 (xx)
PL (1) PL184861B1 (xx)
PT (2) PT754678E (xx)
RO (1) RO118656B1 (xx)
RS (1) RS49520B (xx)
RU (1) RU2181123C2 (xx)
SA (1) SA96170491B1 (xx)
SG (1) SG47158A1 (xx)
SI (2) SI1043332T1 (xx)
SK (2) SK284733B6 (xx)
SV (1) SV1996000062A (xx)
TN (1) TNSN96100A1 (xx)
TR (1) TR199600583A2 (xx)
TW (1) TW496737B (xx)
UA (1) UA46725C2 (xx)
YU (1) YU20050685A (xx)
ZA (1) ZA966111B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191306B1 (en) * 1999-08-03 2001-02-20 Eastman Chemical Company Process for the preparation of cyclopropylglycine
KR20010073441A (ko) * 2000-01-14 2001-08-01 최인도 패류종묘 착상판의 제조방법
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
US7659253B2 (en) * 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
EA010295B1 (ru) * 2003-05-29 2008-08-29 ШАЙЕ ЭлЭлСи Соединения амфетамина с пониженной способностью вызывать злоупотребление ими

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716278D0 (en) * 1987-07-10 1987-08-19 Fujisawa Pharmaceutical Co Antimicrobial agent
JPH02174753A (ja) * 1988-08-25 1990-07-06 Fujisawa Pharmaceut Co Ltd シス―２―アミノシクロペンタンカルボン酸誘導体およびその製法ならびに抗菌剤
DE4302155A1 (de) * 1993-01-27 1994-07-28 Bayer Ag Verwendung von Cyclopentan- und -penten-beta-Aminosäuren
US5631291A (en) * 1992-05-29 1997-05-20 Bayer Aktiengesellschaft Cyclopentane- and -pentene-β-amino acids
AU673824B2 (en) * 1992-05-29 1996-11-28 Bayer Aktiengesellschaft Cyclopentane- and -pentene-beta-amino acids
GB9216441D0 (en) * 1992-08-03 1992-09-16 Ici Plc Fungicidal process
WO1995007022A1 (en) * 1993-09-07 1995-03-16 Zeneca Limited Fungicides
DE19548825C2 (de) * 1995-12-27 1999-03-25 Rolf Dr Hermann Neue, substituierte Cyclopentylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19604225A1 (de) * 1996-02-06 1997-08-07 Bayer Ag Stoffzusammensetzungen aus alpha-Aminosäuren und Cyclohexen-beta-aminosäuren

Also Published As

Publication number Publication date
CO4700525A1 (es) 1998-12-29
AU713555B2 (en) 1999-12-02
NO963000L (no) 1997-01-20
HK1005131A1 (en) 1998-12-24
YU41796A (sh) 1999-06-15
SI0754678T1 (en) 2001-04-30
PT754678E (pt) 2001-04-30
DE19526274A1 (de) 1997-01-23
DZ2073A1 (fr) 2002-07-22
HU9601977D0 (en) 1996-09-30
CZ287896B6 (cs) 2001-03-14
AU5948896A (en) 1997-01-23
BR9603124A (pt) 1998-04-22
EE9600109A (et) 1997-02-17
ES2154761T3 (es) 2001-04-16
SI1043332T1 (sl) 2007-04-30
DK1043332T3 (da) 2007-03-12
TW496737B (en) 2002-08-01
BG100716A (bg) 1997-04-30
SG47158A1 (en) 1998-03-20
KR100433968B1 (ko) 2004-08-30
SA96170491B1 (ar) 2006-09-20
KR970006312A (ko) 1997-02-19
CU22820A3 (es) 2003-01-29
CZ288204B6 (en) 2001-05-16
SK281850B6 (sk) 2001-08-06
MX9602836A (es) 1997-01-31
ATE344274T1 (de) 2006-11-15
GR3035601T3 (en) 2001-06-29
MA23940A1 (fr) 1997-04-01
HRP960303A2 (en) 1998-02-28
PL184861B1 (pl) 2003-01-31
DE59611398D1 (de) 2006-12-14
IL118869A0 (en) 1996-10-31
DE59606266D1 (de) 2001-02-08
EP0754678A2 (de) 1997-01-22
CN1115145C (zh) 2003-07-23
HUP9601977A2 (en) 1997-05-28
EP0754678A3 (de) 1997-12-17
TR199600583A2 (tr) 1997-02-21
ATE198469T1 (de) 2001-01-15
BG62134B1 (bg) 1999-03-31
CA2181308A1 (en) 1997-01-20
US5935988A (en) 1999-08-10
PL315330A1 (en) 1997-01-20
EP1043332A1 (de) 2000-10-11
TNSN96100A1 (fr) 2005-03-15
SK94796A3 (en) 1997-02-05
HRP960303B1 (en) 2001-08-31
ES2275460T3 (es) 2007-06-16
SV1996000062A (es) 1997-06-26
EP1043332B1 (de) 2006-11-02
JP2007056026A (ja) 2007-03-08
UA46725C2 (uk) 2002-06-17
JPH09202761A (ja) 1997-08-05
NO963000D0 (no) 1996-07-18
JP3891503B2 (ja) 2007-03-14
IL118869A (en) 2002-03-10
RO118656B1 (ro) 2003-08-29
CZ214396A3 (en) 1997-02-12
NZ299008A (en) 1998-05-27
AR003465A1 (es) 1998-08-05
NO315926B1 (no) 2003-11-17
EP0754678B1 (de) 2001-01-03
PT1043332E (pt) 2007-01-31
RS49520B (sr) 2006-10-27
HUP9601977A3 (en) 1998-04-28
DK0754678T3 (da) 2001-02-05
CN1143496A (zh) 1997-02-26
SK284733B6 (sk) 2005-10-06
YU20050685A (sh) 2006-08-17
ZA966111B (en) 1997-02-03
RU2181123C2 (ru) 2002-04-10
PE9398A1 (es) 1998-04-15

Similar Documents

Publication Publication Date Title
EE04375B1 (et) Modifitseeritud aminohapped, neid ühendeid sisaldavad ravimid ja nende valmistamise meetod
FI964473A (fi) Uudet aminohappojohdannaiset, menetelmä niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset (II)
AU7562296A (en) Novel amino acid derivatives, methods of producing them, and pharmaceutical compounds containing these compounds
HUP9602507A3 (en) Cyclic peptides, adhesion inhibitor pharmaceutical compositions comprising the compounds, process for the preparation of the compounds and the pharmaceutical compositions and the use of the compounds
ATE221531T1 (de) Kristallmodifikation des cdch, verfahren zu dessen herstellung und diese enthaltende pharmazeutische zubereitungen
FI942076A (fi) Sappihappojohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkaaineina
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
EE9600019A (et) 2,8-diasendatud kinasolinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
EE9600030A (et) N-(3-bensofuranüül)karbamiidderivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud ühendeid sisaldavad ravimid ja nende valmistamismeetod
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
HK1019327A1 (en) Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
CZ129596A3 (en) Oxazolidinone derivative, process of its preparation and pharmaceutical composition containing thereof
DE69124769D1 (de) Verfahren zur Herstellung von (1'R,3S)-3-(1'-hydroxy-ethyl)-Azetidin-2-on und deren Derivaten
ATE56956T1 (de) (s)-(-)-1-propyl-2',6'-pipecoloxylididhydrochloridmonohydrat, verfahren zu seiner herstellung und es enthaltendes pharmazeutisches praeparat.
EE03395B1 (et) Bensotiasolooni derivaadid, protsessid ja kasutatud vaheühendid nende saamiseks ning neid sisaldavad ravimkoostised
EE03803B1 (et) a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid
CZ92295A3 (en) Boronpeptide derivatives, process of their preparation and pharmaceutical composition containing thereof
CZ346595A3 (en) Substituted derivatives of 4-phenylthiazoles, process of their preparation and pharmaceutical compositions containing thereof
EE9600023A (et) Fenüültsükloheksüülkarboksüülhappeamiidid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud ühendeid sisaldavad ravimid ja nende valmistamismeetod
FI960316A (fi) Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
HUP9601680A3 (en) Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds
HUP9602324A3 (en) Piperidinyl-methyl-oxazolidinon derivatives, pharmaceutical compositions containing the same, process for the preparation of the compounds and use of them
HRP960076B1 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and the use of pharmaceutical preparations based on these compounds, as well as medicaments containing them
NO960664D0 (no) Substituerte benzensulfonylureaer og -tioureaer, fremgangsmåter for deres fremstilling, deres anvendelse for fremstilling av farmasöytiske preparater og medikamenter inneholdende disse
FI972129A (fi) 6-metoksi-1H-bentsotriatsoli-5-karboksamidijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä lääkekoostumuksia

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20080718